AIP · Arteris, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $70.58M | $57.72M | $53.67M | $50.38M | $31.81M |
| Cost of Revenue | $6.89M | $5.96M | $5.08M | $4.28M | $1.49M |
| Gross Profit | $63.68M | $51.76M | $48.59M | $46.10M | $30.32M |
| R&D | $49.91M | $45.01M | $45.13M | $41.17M | $17.02M |
| SG&A | $20.13M | $17.55M | $17.94M | $16.37M | $7.33M |
| Total Operating Expenses | $96.82M | $83.36M | $83.73M | $74.95M | $34.10M |
| D&A | $3.38M | $3.36M | $3.07M | $2.10M | $935.0K |
| Operating Income | ($33.14M) | ($31.60M) | ($35.14M) | ($28.86M) | ($3.78M) |
| Interest Expense | $193.0K | $200.0K | $211.0K | $89.0K | $100.0K |
| Income Tax | $1.48M | $2.50M | $1.68M | ($417.0K) | $1.03M |
| Net Income | ($34.75M) | ($33.64M) | ($36.87M) | ($27.39M) | ($3.26M) |
| EPS - Basic | ($0.82) | ($0.86) | ($1.03) | ($0.84) | ($0.19) |
| EPS - Diluted | ($0.82) | ($0.86) | ($1.03) | ($0.84) | ($0.19) |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $33.90M | $13.68M | $13.70M | $37.42M | $85.83M |
| Accounts Receivable | $19.18M | $20.61M | $12.00M | $7.14M | $13.87M |
| Inventory | - | - | - | - | - |
| Accounts Payable | $340.0K | $539.0K | $183.0K | $572.0K | $1.72M |
| Current Assets | $82.39M | $69.08M | $58.43M | $81.11M | $106.65M |
| Total Assets | $115.03M | $106.14M | $102.80M | $115.52M | $120.44M |
| Current Liabilities | $73.20M | $59.28M | $46.40M | $43.67M | $42.49M |
| Long-term Debt | - | - | - | - | - |
| Total Liabilities | $129.66M | $107.32M | $87.70M | $77.98M | $67.54M |
| Stockholders' Equity | ($14.63M) | ($1.19M) | $15.10M | $37.53M | $52.90M |
| Retained Earnings | ($171.63M) | ($136.88M) | ($103.25M) | ($66.38M) | ($38.99M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6.73M | ($720.0K) | ($15.73M) | ($6.77M) | $2.16M |
| Investing Cash Flow | $12.03M | $970.0K | ($4.69M) | ($37.48M) | ($5.15M) |
| Financing Cash Flow | $1.42M | ($262.0K) | ($2.92M) | ($4.15M) | $790.0K |
| CapEx | $1.39M | $324.0K | $1.50M | $1.05M | $654.0K |
| Free Cash Flow | $5.34M | ($1.04M) | ($17.23M) | ($7.82M) | $1.51M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 90.2% | 89.7% | 90.5% | 91.5% | 95.3% |
| Operating margin | -47.0% | -54.7% | -65.5% | -57.3% | -11.9% |
| EBITDA margin | -42.2% | -48.9% | -59.8% | -53.1% | -8.9% |
| Net margin | -49.2% | -58.3% | -68.7% | -54.4% | -10.2% |
| Free cash flow margin | 7.6% | -1.8% | -32.1% | -15.5% | 4.7% |
| FCF / Net income | -0.15 | 0.03 | 0.47 | 0.29 | -0.46 |
| R&D / Revenue | 70.7% | 78.0% | 84.1% | 81.7% | 53.5% |
| SG&A / Revenue | 28.5% | 30.4% | 33.4% | 32.5% | 23.0% |
| Effective tax rate | - | - | - | - | - |
| Return on assets | -30.2% | -31.7% | -35.9% | -23.7% | -2.7% |
| Return on equity | 237.5% | 2831.5% | -244.1% | -73.0% | -6.2% |
| Return on invested capital | - | - | - | - | - |
| Liquidity | |||||
| Current ratio | 1.13 | 1.17 | 1.26 | 1.86 | 2.51 |
| Quick ratio | 1.13 | 1.17 | 1.26 | 1.86 | 2.51 |
| Cash ratio | 0.46 | 0.23 | 0.30 | 0.86 | 2.02 |
| Leverage | |||||
| Debt / Equity | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - |
| Interest coverage | -171.7x | -158.0x | -166.5x | -324.2x | -37.8x |
| Equity multiplier | -7.86 | -89.34 | 6.81 | 3.08 | 2.28 |
| Liabilities / Assets | 1.13 | 1.01 | 0.85 | 0.68 | 0.56 |
| Efficiency | |||||
| Asset turnover | 0.61 | 0.54 | 0.52 | 0.44 | 0.26 |
| Inventory turnover | - | - | - | - | - |
| Days sales outstanding | 99d | 130d | 82d | 52d | 159d |
| Days inventory outstanding | - | - | - | - | - |
| Days payable outstanding | 18d | 33d | 13d | 49d | 422d |
| Cash conversion cycle | - | - | - | - | - |
| Valuation | |||||
| P / E | - | - | - | - | - |
| P / B | - | - | 13.9x | 3.7x | 7.0x |
| P / S | 9.3x | 6.9x | 3.9x | 2.8x | 11.7x |
| EV / EBITDA | - | - | - | - | - |
| Growth | |||||
| Revenue growth (YoY) | 22.3% | 7.6% | 6.5% | 58.4% | - |
| Revenue CAGR (3y) | 11.9% | 22.0% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - |
| Gross profit growth (YoY) | 23.0% | 6.5% | 5.4% | 52.0% | - |
| Operating income growth (YoY) | -4.9% | 10.1% | -21.8% | -664.0% | - |
| Net income growth (YoY) | -3.3% | 8.8% | -34.6% | -740.1% | - |
| EPS growth (YoY) | 4.7% | 16.5% | -22.6% | -342.1% | - |
| EPS CAGR (3y) | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - |
| FCF growth (YoY) | - | 93.9% | -120.4% | - | - |
| FCF CAGR (5y) | - | - | - | - | - |
| Book value growth (YoY) | -1131.6% | - | -59.8% | -29.1% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$77.30M totalLicense And Maintenance$63.86M · 82.6%
Variable Royalties And Other$6.72M · 8.7%
Royalty$6.60M · 8.5%
Service Other$124.0K · 0.2%
Geographic
$133.49M totalAsia Pacific$33.60M · 25.2%
Americas$29.31M · 22.0%
US$28.01M · 21.0%
CN$17.27M · 12.9%
KR$8.57M · 6.4%
Other Asia$7.76M · 5.8%
Europe And Middle East$7.67M · 5.7%
Other Americas$1.30M · 1.0%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
-1.54
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Semiconductors & Related Devices
Comparing Arteris against the 5 most active filers in the same SIC group.